A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants
Clinical trial NCT00479648 · COMPLETED
Trial details
- NCT number
- NCT00479648
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2007-08-01
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.